D-Dimer Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

D-Dimer is a fibrin degradation product (FDP) that has two cross-linked D fragments of fibrin formed by the degradation of blood clots, known as fibrinolysis. D-Dimers form in the blood plasma only when the blood coagulation system gets activated due to disseminated intravascular coagulation or thrombosis and thus activates the hemostatic system. The D-Dimer Market is Segmented by Testing Method (Point of Care Testing and Laboratory Testing), Application (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Venous Thromboembolism (VTE), Other Applications), Distribution Channel (Diagnostic Laboratories, Hospitals, and Other Distribution Channels), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

D-Dimer Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

D-Dimer Industry Overview

The D-Dimer market is moderately competitive and consists of several major players. Few of the key players are entering into partnerships to develop novel methods and test kits, while others are increasing their sales force through partnering with distributors to increase their market position globally. Some of the companies which are currently operating in the market are F. Hoffmann-La Roche Ltd, Abbott Laboratories, Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Danaher Corporation (Beckton Dickinson), BioMerieux, Sysmex Corporation, Henry Schein Inc., and Merck KGaA.

D-Dimer Market Leaders

  1. F. Hoffmann-La Roche Ltd

  2. Bio-Rad Laboratories Inc

  3. Thermo Fisher Scientific

  4. Henry Schein, Inc.

  5. Bio-Rad Laboratories Inc

  6. *Disclaimer: Major Players sorted in no particular order
dimer CL.png